Header Logo

Connection

JENNIFER LEIGH MCQUADE to Interleukin-2

Back to Details
This is a "connection" page, showing publications JENNIFER LEIGH MCQUADE has written about Interleukin-2.
JENNIFER LEIGH MCQUADE
Connection Strength
0.497
Interleukin-2
  1. A phase II trial of recombinant MAGE-A3 protein with immunostimulant AS15 in combination with high-dose Interleukin-2 (HDIL2) induction therapy in metastatic melanoma. BMC Cancer. 2018 Dec 19; 18(1):1274.
    View in: PubMed
    Score: 0.497
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.